<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVE: Our purpose was to determine whether patients with severe early-<z:hpo ids='HP_0003674'>onset</z:hpo> <z:e sem="disease" ids="C0032914" disease_type="Disease or Syndrome" abbrv="PEE|PREG1|PEE1">preeclampsia</z:e> have hemostatic or <z:mp ids='MP_0005266'>metabolic abnormalities</z:mp> that are associated with a tendency to vascular <z:mp ids='MP_0005048'>thrombosis</z:mp> </plain></SENT>
<SENT sid="1" pm="."><plain>STUDY DESIGN: A total of 101 patients with a history of severe early-<z:hpo ids='HP_0003674'>onset</z:hpo> <z:e sem="disease" ids="C0032914" disease_type="Disease or Syndrome" abbrv="PEE|PREG1|PEE1">preeclampsia</z:e> were tested at least 10 weeks post partum for the presence of <z:e sem="disease" ids="C0598608" disease_type="Disease or Syndrome" abbrv="">hyperhomocysteinemia</z:e> (methionine loading test), protein C, protein S, and <z:hpo ids='HP_0001976'>antithrombin III deficiency</z:hpo>, activated protein C resistance, <z:e sem="disease" ids="C0024138,C0024141,C0024131,C0409974" disease_type="Disease or Syndrome" abbrv="">lupus</z:e> <z:chebi fb="3" ids="50249">anticoagulant</z:chebi>, and immunoglobulin G and/or M anticardiolipin antibodies </plain></SENT>
<SENT sid="2" pm="."><plain>RESULTS: Of the 101 patients, 39 (38.6%) had <z:hpo ids='HP_0011010'>chronic</z:hpo> <z:hpo ids='HP_0000822'>hypertension</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain>Of the 85 patients tested for coagulation disturbances, 21 (24.7%) had <z:e sem="disease" ids="C0242666" disease_type="Disease or Syndrome" abbrv="">protein S deficiency</z:e> </plain></SENT>
<SENT sid="4" pm="."><plain>Of the 50 patients tested for activated protein C resistance, 8 (16.0%) were positive </plain></SENT>
<SENT sid="5" pm="."><plain>Of the 79 patients tested for <z:e sem="disease" ids="C0598608" disease_type="Disease or Syndrome" abbrv="">hyperhomocysteinemia</z:e>, 14 (17.7%) had a positive methionine loading test </plain></SENT>
<SENT sid="6" pm="."><plain>Finally, 95 patients were tested for anticardiolipin antibodies; 27 (29.4%) had detectable immunoglobulin G and/or M anticardiolipin antibodies </plain></SENT>
<SENT sid="7" pm="."><plain>CONCLUSION: Patients with a history of severe early-<z:hpo ids='HP_0003674'>onset</z:hpo> <z:e sem="disease" ids="C0032914" disease_type="Disease or Syndrome" abbrv="PEE|PREG1|PEE1">preeclampsia</z:e> should be screened for <z:e sem="disease" ids="C0242666" disease_type="Disease or Syndrome" abbrv="">protein S deficiency</z:e>, activated protein C resistance, <z:e sem="disease" ids="C0598608" disease_type="Disease or Syndrome" abbrv="">hyperhomocysteinemia</z:e>, and anticardiolipin antibodies, since these results may have an impact on counseling for and pharmacologic management in future pregnancies </plain></SENT>
</text></document>